Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Axogen (AXGN) Shares Outstanding (Diluted Average) (2019 - 2025)

Historic Shares Outstanding (Diluted Average) for Axogen (AXGN) over the last 9 years, with Q3 2025 value amounting to $49.1 million.

  • Axogen's Shares Outstanding (Diluted Average) rose 1186.43% to $49.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.1 million, marking a year-over-year increase of 1186.43%. This contributed to the annual value of $44.3 million for FY2024, which is 321.66% up from last year.
  • According to the latest figures from Q3 2025, Axogen's Shares Outstanding (Diluted Average) is $49.1 million, which was up 1186.43% from $48.0 million recorded in Q2 2025.
  • Axogen's Shares Outstanding (Diluted Average)'s 5-year high stood at $49.1 million during Q3 2025, with a 5-year trough of $40.7 million in Q1 2021.
  • In the last 5 years, Axogen's Shares Outstanding (Diluted Average) had a median value of $42.9 million in 2023 and averaged $43.2 million.
  • In the last 5 years, Axogen's Shares Outstanding (Diluted Average) soared by 155.53% in 2024 and then skyrocketed by 1186.43% in 2025.
  • Over the past 5 years, Axogen's Shares Outstanding (Diluted Average) (Quarter) stood at $41.2 million in 2021, then increased by 2.11% to $42.1 million in 2022, then rose by 1.89% to $42.9 million in 2023, then increased by 3.22% to $44.3 million in 2024, then rose by 10.91% to $49.1 million in 2025.
  • Its last three reported values are $49.1 million in Q3 2025, $48.0 million for Q2 2025, and $45.2 million during Q1 2025.